These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 35734429
1. N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma. Regmi P, He ZQ, Lia T, Paudyal A, Li FY. Front Genet; 2022; 13():918983. PubMed ID: 35734429 [Abstract] [Full Text] [Related]
2. Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma. Wang H, Shui X, Zhang Z, He M, Tai S, Lin Y. Transl Cancer Res; 2024 Jun 30; 13(6):2799-2811. PubMed ID: 38988942 [Abstract] [Full Text] [Related]
3. N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma. Zhou K, Yang J, Li X, Xiong W, Zhang P, Zhang X. Front Surg; 2022 Jun 30; 9():893977. PubMed ID: 35784919 [Abstract] [Full Text] [Related]
4. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation. Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X. Front Genet; 2022 Jun 30; 13():929035. PubMed ID: 36081998 [Abstract] [Full Text] [Related]
5. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma. Li Y, Zhao K, Wu R, Wang J, Wang Q, Xiong Q, Xie F, Lei H, Feng P. J Gastrointest Oncol; 2023 Jun 30; 14(3):1392-1411. PubMed ID: 37435203 [Abstract] [Full Text] [Related]
6. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. Dai YY, Gao YP, Chen LX, Liu JS, Zeng C, Zhou JD, Wu HL. Front Genet; 2022 Jun 30; 13():930446. PubMed ID: 36110218 [Abstract] [Full Text] [Related]
7. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification. Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J. Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684 [Abstract] [Full Text] [Related]
8. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival. Liu P, Dong C, Shi H, Yan Z, Zhang J, Liu J. J Gastrointest Oncol; 2022 Dec 28; 13(6):3169-3182. PubMed ID: 36636051 [Abstract] [Full Text] [Related]
9. A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification. Yang L, Wang YR, Mou ZQ, Xiong PF, Deng K, Wen J, Li J. BMC Gastroenterol; 2023 Apr 20; 23(1):131. PubMed ID: 37081394 [Abstract] [Full Text] [Related]
10. Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma. Peng YL, Dong YF, Guo LL, Li MY, Liao H, Li RS. PLoS One; 2023 Apr 20; 18(8):e0289552. PubMed ID: 37535570 [Abstract] [Full Text] [Related]
11. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer. Ren L, Yang X, Liu J, Wang W, Liu Z, Lin Q, Huang B, Pan J, Mao X. Cancer Cell Int; 2023 May 08; 23(1):85. PubMed ID: 37158958 [Abstract] [Full Text] [Related]
12. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma. Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S. Front Genet; 2022 May 08; 13():906496. PubMed ID: 35938009 [Abstract] [Full Text] [Related]
13. Prognostic model and ceRNA network of m7G- and radiosensitivity-related genes in hepatocellular carcinoma. Liu M, Zhu M, Huang Y, Wu J, Peng Z, Liang Y. Heliyon; 2024 May 15; 10(9):e29925. PubMed ID: 38707306 [Abstract] [Full Text] [Related]
14. Three molecular subtypes and a five-gene signature for hepatocellular carcinoma based on m7G-related classification. Yue Y, Tao J, An D, Shi L. J Gene Med; 2024 Jan 15; 26(1):e3611. PubMed ID: 37847055 [Abstract] [Full Text] [Related]
15. A signature of five 7-methylguanosine-related genes is a prognostic marker for lung squamous cell carcinoma. Liu W, Wang Y, Ulivi P, Tavolari S, Rizvi SAA, Capobianco E, Navarro A, Zhang Y. J Thorac Dis; 2023 Nov 30; 15(11):6265-6278. PubMed ID: 38090319 [Abstract] [Full Text] [Related]
16. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer. Dai D, Zhuang H, Shu M, Chen L, Long C, Wu H, Chen B. Heliyon; 2024 Apr 30; 10(8):e29326. PubMed ID: 38628712 [Abstract] [Full Text] [Related]
17. Comprehensive Analysis of Molecular Clusters and Prognostic Signature Based on m7G-related LncRNAs in Esophageal Squamous Cell Carcinoma. Zhao F, Dong Z, Li Y, Liu S, Guo P, Zhang D, Li S. Front Oncol; 2022 Apr 30; 12():893186. PubMed ID: 35912250 [Abstract] [Full Text] [Related]
18. N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy. Ma L, Ma Q, Deng Q, Zhou J, Zhou Y, Wei Q, Huang Z, Lao X, Du P. Aging (Albany NY); 2023 Nov 03; 15(21):12192-12208. PubMed ID: 37925170 [Abstract] [Full Text] [Related]
19. Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer. Li K, Wang W. Front Genet; 2022 Nov 03; 13():981392. PubMed ID: 36313441 [Abstract] [Full Text] [Related]
20. M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients. Li DX, Feng DC, Wang XM, Wu RC, Zhu WZ, Chen K, Han P. Eur J Med Res; 2023 Feb 02; 28(1):55. PubMed ID: 36732869 [Abstract] [Full Text] [Related] Page: [Next] [New Search]